Table 2. Estimated Annual Infection Risks.
Model output using soil ingestion estimates from the U.S. EPA Exposure Factors Handbook | |||||
---|---|---|---|---|---|
estimated annual risk of G. duodenalis infection |
|||||
percentile | 10th (%) | 50th (%) | 90th (%) | MapSan point prevalence | |
age | <6 months | 9.6 | 15 | 29 | 13 |
6–11 months | 16 | 26 | 54 | 22 | |
12–23 months | 20 | 31 | 48 | 59 | |
24–71 months | 13 | 21 | 38 | 73 | |
estimated annual risk of Shigella/EIEC infection | point prevalence | ||||
age | <6 months | 4.4 | 7.3 | 14 | 5.0 |
6–11 months | 7.2 | 12 | 20 | 21 | |
12–23 months | 9.4 | 15 | 25 | 36 | |
24–71 months | 5.9 | 10 | 19 | 68 |
Model output using soil ingestion estimates from Kwong et al. 2019 | |||||
---|---|---|---|---|---|
estimated annual risk of G. duodenalis infection |
|||||
percentile | 10th (%) | 50th (%) | 90th (%) | MapSan point prevalence | |
age | 3–5 months | 39 | 57 | 83 | 13 |
6–11 months | 50 | 69 | 90 | 22 | |
12–23 months | 53 | 71 | 96 | 59 | |
24–35 months | 40 | 57 | 80 | 72 | |
36–47 months | 43 | 62 | 83 | 75 | |
estimated annual risk of Shigella/EIEC infection | point prevalence | ||||
age | 3–5 months | 19 | 29 | 45 | 5.0 |
6–11 months | 25 | 36 | 51 | 21 | |
12–23 months | 28 | 40 | 56 | 36 | |
24–35 months | 21 | 31 | 47 | 56 | |
36–47 months | 21 | 32 | 47 | 73 |
Model output using geophagy estimates from Geisler et al. 1997 | |||||
---|---|---|---|---|---|
estimated annual risk of G. duodenalis infection |
|||||
percentile | 10th (%) | 50th (%) | 90th (%) | ||
geophagy | >99% | >99 | >99 | ||
estimated annual risk of Shigella/EIEC infection | |||||
geophagy | >99% | >99 | >99 |
Note: MapSan point prevalence data represents a total of 922 children enrolled in the MapSan trial. Annual risk is for a single infection.